Legal Representation
Attorney
Paul J. Kennedy
USPTO Deadlines
Next Deadline
1833 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-16)
Due Date
July 16, 2030
Grace Period Ends
January 16, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 11, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jul 16, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jul 16, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 16, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 11, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jun 11, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| May 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 20, 2024 | ALIE | A | ASSIGNED TO LIE |
| Dec 21, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 28, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 28, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 28, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Sep 7, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Sep 6, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Aug 28, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Aug 28, 2023 | IUAF | S | USE AMENDMENT FILED |
| Feb 28, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 3, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 3, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 14, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 30, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 30, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 18, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 18, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Scientific research and development; scientific research and development in the field of protein expression and cell expression systems for use in the production of biomolecules; pharmaceutical, medical, and biological research and development services in the field of protein expression, antibody production, cell line establishment, and cell culture production of proteins for scientific, therapeutic and medical use
First Use Anywhere:
Jul 20, 2016
First Use in Commerce:
Jul 20, 2016
Classification
International Classes
042